<DOC>
	<DOCNO>NCT02381795</DOCNO>
	<brief_summary>This open label , investigator-sponsored , pilot study . Subjects agree participate study meeting eligibility criterion assess screen visit enrol study . The length time screen treatment last 0 day maximum 12 week . Subjects enter screen phase cluster headache episode meet study eligibility criterion immediately enter treatment phase may opt treat cluster headache episode clinic . Subjects cluster headache episode , meet initial screen eligibility criterion , remain screening phase 12 week next cluster episode begin . Upon initiation cluster headache episode , subject enter treatment period . Subjects train proper use hand-held dispenser contain carbon dioxide ( CO2 ) calibrate deliver 0.5 standard liter per minute ( SLPM ) . This dispenser provide use clinic home . Subjects instruct use nasal CO2 dispenser , 10 seconds/nostril , need 6 time treat one attack . Each dose must separate 3-5 minute . Subjects treat one attack 24-hour period . Subjects may treat three cluster headache attack treatment phase study . One hour first dose , subject choose treat investigator-approved rescue medication . Subjects ask complete online diary completion dose . Diary assessment collect pain severity , nasal CO2 usage , acute medication usage , satisfaction treatment , number cluster attack , unusual symptom . Subjects contact phone within 3 day first use nasal CO2 dispenser ass adverse event ( AEs ) medication usage . A total 25 subject enter treatment period instruct treat 3 cluster headache nasal CO2 . Within 7 day treat last cluster headache episode , subject return end study visit .</brief_summary>
	<brief_title>Pilot Study Evaluating Use Nasal Carbon Dioxide Treatment Cluster Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Male female , 18 year age old . History episodic cluster headache , define International Classification Headache Disorders ( ICHD ) , third edition , beta version guideline ( ICHD3 beta , Cephalalgia 2013 ) . History cluster headache attackfree remission period last &gt; 1 month within previous year . Stable medication , include treatment cluster headache prevention/prophylaxis , least 60 day prior baseline ( include , limited , verapamil , lithium , melatonin , anticonvulsant , systemic corticosteroid steroid injection , occipital nerve block , cranial extracranial nerve block , neurostimulation treatment ) . Note : Subjects allow use usual standard care acute/abortive treatment acute cluster attack 60 minute initial dose , limited following : triptans ; highflow oxygen . If female childbearing potential , negative urine pregnancy test time Screening . . To consider childbearing potential subject must surgically sterile , hysterectomy tubal ligation , postmenopausal least 1 year , otherwise incapable pregnancy . Capable complete online headache diary access internet . Able provide write Informed Consent . Recent nasal/midface trauma ( &lt; 3 month ) Recent nasal/sinus surgery ( &lt; 3 month ) . Severe respiratory distress last 6 month . Neoplasm Angiofibroma , sinus tumor , granuloma . Nasal congestion present 10 day fever ( temperature ≥ 100.4 °F ) nasal mucous abnormal color . Surgery treat cluster headache . History aneurysm , intracranial hemorrhage , brain tumor significant head trauma . Structural intracranial cervical vascular lesion may potentially cause headache attack . Other significant pain problem ( include cancer pain , fibromyalgia , trigeminal neuralgia ) might confound study assessment investigator opinion . Psychiatric disorder , opinion Investigator , may interfere study . Pregnant , actively try become pregnant , breastfeeding , and/or unwilling use accept form birth control . Skin around inside nasal passage dry , crack , ooze , bleed . Recurrent nose bleeds , opinion Investigator , may interfere study . Is participate therapeutic clinical investigation participate clinical trial receive treatment precede 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>